Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study (Q40316484)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2015
edit
Language Label Description Also known as
English
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study
scientific article published on June 2015

    Statements

    Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study (English)
    Alzheimer’s Disease Neuroimaging Initiative
    0 references
    0 references
    0 references
    Nandini Raghavan
    David Baker
    Michael T Ropacki
    Gerald Novak
    David Ames
    Kathryn Ellis
    Ralph N Martins
    Paul Maruff
    Gary Romano
    Christopher C Rowe
    S Lance Macaulay
    Vaibhav A Narayan
    AIBL Research Group
    1 June 2015
    1079-1089

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit